Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity (New Diabetes Company).

In a surprise move, Medtronic plans to spin off its diabetes business. This is Medtronic's smallest business, but also its fastest-growing one. The new entity could be attractive to more growth ...

Medical-device maker Medtronic MDT 0.71% plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than 8,000 global employees and carry a nearly $3 billion portfolio | The ...

Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts. The revenue miss came as sales of its stapling and blood oxygen management products slowed.

Medtronic said that the FDA approved its new spinal implant, which delivers a variable electrical pulse to interrupt pain signals before they reach the brain.

Utilizing user-friendly, swiftly applicable electrodes, subhairline EEG may improve stroke detection and reduce time to treatment for anterior circulation large vessel occlusion stroke.